Rockefeller Capital Management
CCCC icon

Rockefeller Capital Management’s C4 Therapeutics CCCC Stock Holding History

Rockefeller Capital Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
+495,817
New +$1.7M ﹤0.01% 1318
2023
Q1 		– Sell
-11,859
Closed -$69K – 2265
2022
Q4 		$69K Hold
11,859
– – ﹤0.01% 2223
2022
Q3 		$104K Hold
11,859
– – ﹤0.01% 1966
2022
Q2 		$89K Sell
11,859
-400
-3% -$3.52K ﹤0.01% 2003
2022
Q1 		$297K Buy
12,259
+11,859
+2,965% +$288K ﹤0.01% 1532
2021
Q4 		$12K Hold
400
– – ﹤0.01% 2879
2021
Q3 		$17K Buy
+400
New +$17.1K ﹤0.01% 2646

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rockefeller Capital Management's CCCC Position: Q2 2026 in Review

Rockefeller Capital Management opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 495,817 shares worth $2.32M. The stake represents ﹤0.01% of the portfolio and ranks #1318 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in CCCC as recently as Q4 2022.

Rockefeller Capital Management first reported a position in CCCC in Q3 2021 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Rockefeller Capital Management held 495,817 shares of C4 Therapeutics worth $2.32M as of Q2 2026.
  • C4 Therapeutics was a new Rockefeller Capital Management position in Q2 2026.
  • C4 Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1318 holding.
  • Rockefeller Capital Management first reported a position in C4 Therapeutics in Q3 2021 and has held it in 7 quarters since.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.